SETD2 and leukemia: Notably, with NSD1, and ASH1L, two other H3K36 methyltransferases, SETD2 were demonstrated as a critical gene in the development of castration-resistant prostate cancer (CRPC), similar to MLL complex family members as described above for leukemia [80].